VIKING THERAPEUTICS INC's ticker is VKTX and the CUSIP is 92686J106. A total of 141 filers reported holding VIKING THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.44 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $8,221,851 | -22.5% | 155,100 | +20.0% | 0.06% | -6.7% |
| Q1 2024 | $10,602,600 | +617.0% | 129,300 | +62.7% | 0.06% | +500.0% |
| Q4 2023 | $1,478,732 | +1209.6% | 79,459 | +679.0% | 0.01% | +900.0% |
| Q3 2023 | $112,914 | -98.5% | 10,200 | -97.8% | 0.00% | -98.0% |
| Q2 2023 | $7,399,654 | +108.4% | 456,487 | +114.1% | 0.05% | +127.3% |
| Q1 2023 | $3,550,541 | +8.7% | 213,246 | -38.6% | 0.02% | +15.8% |
| Q4 2022 | $3,266,660 | +313.5% | 347,517 | +19.7% | 0.02% | +375.0% |
| Q3 2022 | $790,000 | -17.5% | 290,272 | -12.4% | 0.00% | -33.3% |
| Q2 2022 | $958,000 | +13.1% | 331,536 | +17.4% | 0.01% | -14.3% |
| Q1 2022 | $847,000 | +327.8% | 282,306 | +554.6% | 0.01% | +250.0% |
| Q4 2021 | $198,000 | +51.1% | 43,124 | +97.7% | 0.00% | +100.0% |
| Q2 2021 | $131,000 | -28.8% | 21,810 | -25.2% | 0.00% | -50.0% |
| Q1 2021 | $184,000 | +33.3% | 29,169 | +19.2% | 0.00% | 0.0% |
| Q4 2020 | $138,000 | -9.8% | 24,465 | -6.8% | 0.00% | 0.0% |
| Q3 2020 | $153,000 | -22.7% | 26,247 | -4.4% | 0.00% | -33.3% |
| Q2 2020 | $198,000 | -81.5% | 27,449 | -78.8% | 0.00% | -85.0% |
| Q2 2019 | $1,072,000 | +56.0% | 129,196 | +43.9% | 0.02% | -37.5% |
| Q4 2018 | $687,000 | +432.6% | 89,783 | +560.2% | 0.03% | +433.3% |
| Q2 2018 | $129,000 | – | 13,600 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| APIS CAPITAL ADVISORS, LLC | 148,000 | $1,638,360 | 2.12% |
| Sio Capital Management, LLC | 595,002 | $6,586,672 | 2.04% |
| 5AM Venture Management, LLC | 585,000 | $6,475,950 | 1.86% |
| Artia Global Partners LP | 383,580 | $4,246,231 | 1.76% |
| Integral Health Asset Management, LLC | 800,000 | $8,856,000 | 1.23% |
| Boxer Capital, LLC | 2,000,000 | $22,140,000 | 1.18% |
| DAFNA Capital Management LLC | 319,655 | $3,538,581 | 1.10% |
| Affinity Asset Advisors, LLC | 332,600 | $3,681,882 | 1.04% |
| MPM BioImpact LLC | 325,000 | $3,597,750 | 0.96% |
| Affinity Asset Advisors, LLC | 300,000 | $3,321,000 | 0.93% |